Article Index
The Metabolic Switch
Intermittent fasting is not a diet — it is a temporal eating pattern. After 12–16 hours without calories, the body depletes hepatic glycogen and "flips the metabolic switch": it begins using fatty acids and ketones as the main fuel. This mild ketotic state differs from prolonged fasting and is widely safe for healthy adults.
1. What Is Intermittent Fasting?
Intermittent fasting (IF) encompasses different strategies that alternate periods of restricted eating with fasting periods. It is not an evolutionary novelty — our hunter-gatherer ancestors went long periods without food. What changed is our continuous eating for 16+ hours a day.
Modern science, especially after the 2016 Nobel Prize in Medicine (Yoshinori Ohsumi, for the autophagy mechanism), rediscovered the cellular benefits of fasting. Today, dozens of randomized clinical trials evaluate different protocols in metabolic health, weight, cognition and longevity.
2. Fasting Metabolism: From Glycolysis to Ketogenesis
When we eat, blood glucose rises, the pancreas secretes insulin and cells absorb glucose for energy and storage (glycogen and fat). With fasting, this cycle reverses:
- 0–4h: Blood glucose falls; insulin decreases; the liver releases glucose via glycogenolysis.
- 4–12h: Hepatic glycogen depletes; glucagon rises; lipolysis increases — free fatty acids enter the bloodstream.
- 12–18h: The liver converts fatty acids into ketone bodies (beta-hydroxybutyrate, acetoacetate). Ketogenesis begins.
- 18h+: Established ketotic state; intensified autophagy; elevated growth hormone.
Beta-hydroxybutyrate is not just fuel — it is also a molecular signal that regulates aging and inflammation genes via histone deacetylase (HDAC) inhibition.
3. Autophagy: The Nobel-Winning "Cellular Cleanup"
Autophagy (from the Greek: "to eat oneself") is the process by which the cell degrades and recycles damaged components — misfolded proteins, dysfunctional mitochondria, cellular debris. It is the "cleanup" that prevents the accumulation of cellular detritus.
The central sensor of autophagy is the mTORC1 complex. Amino acids and insulin activate mTORC1, which suppresses autophagy. With fasting, the drop in insulin and amino acids deactivates mTORC1, releasing autophagic mechanisms.
Inadequate autophagy is implicated in neurodegenerative diseases (Parkinson's, Alzheimer's), cancer, aging and metabolic syndrome. Periodic fasting may be a form of cellular "preventive maintenance."
4. The 16:8 Protocol — Time-Restricted Eating (TRE)
The 16:8 protocol consists of concentrating all eating within an 8-hour window (e.g., noon to 8pm) and fasting for the remaining 16 hours. It is the protocol with the best adherence and the most studied in long-term clinical trials.
A study published in Cell Metabolism (Sutton et al., 2018) demonstrated that 16:8 with morning-concentrated eating (early TRE) reduced blood pressure, improved insulin sensitivity and reduced appetite — without deliberate caloric restriction.
- Advantage: Easy to follow (skip breakfast or dinner). Low social impact.
- Note: The early eating window (7am–3pm) appears more beneficial than the late one, due to alignment with circadian rhythm.
- Meta-analysis (NEJM 2019): TRE promotes 1–4% body weight loss, improves fasting blood glucose and HbA1c.
5. The 5:2 and OMAD Protocols
| Protocol | Fasting Window | Calories on Fasting Days | Evidence Level |
|---|---|---|---|
| 16:8 (TRE) | 16h fast, 8h eating | No restriction | High (multiple RCTs) |
| 5:2 (Mosley) | 2 days/week with severe caloric restriction | 500 kcal (women) / 600 kcal (men) | Moderate |
| OMAD (One Meal A Day) | 23h fast, 1h eating | No restriction (1 meal) | Low (few RCTs) |
| ADF (Alternate Day Fasting) | Alternating days: complete fast or 25% of calories | 0–500 kcal | Moderate |
The 5:2 protocol, popularized by Dr. Michael Mosley, demonstrated similar efficacy to continuous caloric restriction for weight loss and improvement of metabolic syndrome markers (CALERIE study, JAMA Internal Medicine). It has better long-term adherence for many people than daily restriction.
OMAD is the most extreme version and requires special nutritional attention to ensure adequate protein intake (≥1.6g/kg), micronutrients and fiber in a single meal.
6. Fasting and Fat Loss: Evidence vs. Myths
The most comprehensive meta-analysis (Harris et al., 2018, Obesity) compared IF with continuous caloric restriction in 37 studies and found equivalent efficacy for weight loss and cardiometabolic markers. There is no magic effect — fat loss occurs mainly through total caloric deficit.
IF can facilitate this deficit more sustainably for some people, as it:
- Naturally reduces eating opportunities (less snacking).
- Decreases appetite via ghrelin/cortisol coupling during short fasting.
- Preserves muscle mass better than continuous restriction when there is adequate protein intake in the eating window.
7. Cardiovascular Benefits and Longevity
Beyond weight loss, IF demonstrates independent benefits on cardiovascular health markers: reduction of triglycerides (10–20%), LDL-C (5–8%), systolic blood pressure (3–8 mmHg) and high-sensitivity CRP (inflammatory marker).
In animal models, IF consistently extends lifespan. In humans, longevity data is indirect, but the improvement of all metabolic risk factors suggests long-term benefit.
Contraindications — Who Should Avoid
Absolute: Type 1 diabetes, type 2 diabetes on insulin or sulfonylureas (hypoglycemia risk), history of eating disorders, pregnancy and breastfeeding, growing children and adolescents.
Relative (consult physician): Medications that require food intake, history of hypoglycemia, underweight (BMI <18.5), conditions requiring regular meals (intensive pre-diabetes treatment, certain GI disorders).
8. Conclusion: For Whom Does It Work?
Intermittent fasting is a valid and safe strategy for healthy adults seeking to improve body composition, metabolic health and potentially cellular benefits via autophagy. It is not superior to continuous caloric restriction for weight loss, but may be more sustainable for many profiles.
The key is individualization: choosing the protocol that best fits the lifestyle, monitoring energy, mood and performance, and ensuring that the eating window includes nutrient-dense foods.
References
1. Mattson MP, et al. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19(2):63-80.
2. de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med. 2019;381:2541-2551.
3. Sutton EF, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress. Cell Metab. 2018;27(6):1212-1221.
4. Harris L, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database. 2018;16(2):507-547.
5. Lowe DA, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters. JAMA Intern Med. 2020;180(11):1491-1499.
6. Wilkinson MJ, et al. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids. Cell Metab. 2020;31(1):92-104.
7. Ohsumi Y. Historical landmarks of autophagy research. Cell Res. 2014;24:9-23.
8. Anton SD, et al. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity. 2018;26(2):254-268.